Drug
Edoxaban
Edoxaban: highest development phase Phase 3, developed by Daiichi Sankyo. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Daiichi Sankyo
Trials
| Drug | Phase | Indication |
|---|---|---|
| Edoxaban NCT04730037 | Phase 3 | CTEPH |
| edoxaban tosylate NCT01662908 | Phase 2 | Deep Vein Thrombosis |
| Edoxaban NCT02964949 | Not Applicable | Atrial Fibrillation |
Latest
No recent events.
Follow Edoxaban on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.